Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data
Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data
Davide Rozza, Richard D Riley, Satveer K. Mahil, Edoardo Cipolletta et al.
Citations
6 citations
Journal
The Lancet Rheumatology
Topics
Gout, Hyperuricemia, Uric Acid
Field-Weighted Citation Impact (FWCI)
8.58
article
Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data
Davide Rozza, Richard D Riley, Satveer K. Mahil, Edoardo Cipolletta, Georgina Nakafero, Catherine Smith, Abhishek Abhishek
article en
6 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet RheumatologyVol. 7(12)
Institutions
University of Nottingham (GB), Guy's and St Thomas' NHS Foundation Trust (GB), National Institute for Health and Care Research (GB), Società Italiana di Reumatologia (IT), NIHR Birmingham Biomedical Research Centre (GB)
Funders
University of Nottingham, Università Politecnica delle Marche, Foundation for Research in Rheumatology